Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$110.8M
9 rounds on record
Latest round
$19.4M
Venture round · Apr 2025 · 18 mo ago
Team
201-500
employees, estimated range
Grants
$4M
5 grants · CORDIS
Backers
2
GV, Mubadala Ventures
The money's age
Due for its next round
18 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 10, 2025 Raised a round Venture round $19.4M · SEC Form D Sep 12, 2024 Won a grant $2M · CORDIS Sep 20, 2023 Won a grant $400k · CORDIS Sep 1, 2023 Won a grant $999k · CORDIS Jul 14, 2022 New executive Halawa Alaa, Executive Officer, Director · SEC Form D May 9, 2022 Won a grant $398k · CORDIS Jul 9, 2021 Board appointment David Hsu, Executive Officer, Director · SEC Form D Jun 24, 2021 Raised a round Venture round $70M · SEC Form D Feb 22, 2021 Won a grant $225k · CORDIS Dec 6, 2019 New executive Xiling Shen, Executive Officer, Director · SEC Form D Nov 19, 2019 Raised a round Venture round $4.8M · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Venture round Apr 2025 $19.4M — SEC Form D
Grant Sep 2024 $2M — CORDIS
Grant Sep 2023 $400k — CORDIS
Grant Sep 2023 $999k — CORDIS
Venture round Jun 2022 $16.5M — SEC Form D
Grant May 2022 $398k — CORDIS
Venture round Jun 2021 $70M — SEC Form D
Grant Feb 2021 $225k — CORDIS
Venture round Nov 2019 $4.8M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Xilis, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
William SmytheExecutive Officer, DirectorSEC Form D
Xiling ShenExecutive Officer, DirectorSEC Form D
David HsuExecutive Officer, DirectorSEC Form D
Halawa AlaaExecutive Officer, DirectorSEC Form D
Wesley ChanExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

Overview

Xilis, Inc. has closed. The micro-organosphere (MOS) technology developed at Xilis is now sold by Uniform Bio as MOSgen, a benchtop instrument that makes MOS in your own lab.

People

William Smythe
Executive Officer, Director
Xiling Shen
Executive Officer, Director
David Hsu
Executive Officer, Director
Halawa Alaa
Executive Officer, Director
Wesley Chan
Executive Officer, Director
Alaa Halawa
Director
John de Koning
Director
David Shiaowen
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Durham United States
HQ
200-500 est. staff

Financials

Total raised
$114.8M
Latest round
Venture - Series Unknown
Funding rounds
9
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $19.4M Details
Grant 2024 $2M Details
Grant 2023 $400k Details
Grant 2023 $999k Details
Venture - Series Unknown 2022 $16.5M Details
Grant 2022 $398k Details
Venture - Series Unknown 2021 $70M Details
Grant 2021 $225k Details
Venture - Series Unknown 2019 $4.8M Details